drugset / Trial / NCT04994860

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil

NCT04994860

Phase 1 Completed 20 enrolled Bial - Portela C S.A.
RandomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg on the pharmacokinetics (PK) of sildenafil. * To assess the effect of sildenafil on the PK of BIA 5-1058.

Timeline

Start
2018-03-22
Primary completion
2018-06-07
Completion
2018-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 20 mg Oral
Subject zamicastat Small molecule 400 mg Oral